Adults 14 to 21, male only, with Contraception Behavior. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Eligible Participants Who Agreed to be Enrolled in the StudyPrimary· From day 1 of enrollment until the final day of enrollment (1 year)
Implementation, feasibility: This outcome is designed to measure feasibility - the extent to which an innovation can be used in a setting. The investigators will measure the number of participants who are eligible, and agree to be enrolled into the study.
Group
Value
95% CI
All Eligible Patients
119
Number of Participants That Are Lost to Follow up (at Each Time Point)Primary· 6 and 13 weeks
Implementation, feasibility: This outcome is to measure feasibility for both arms in which feasibility is defined as the extent to which an innovation can be used in a setting. The investigators will measure the number of participants in each arm that are lost to follow up in each respective arm at the 6 and 13 week time point. Lost to follow up means that we tried to contact the participant to assess outcome measures but they did not respond to texts or phone calls.
6 weeks
Group
Value
95% CI
Dr. Eric Digital Health Intervention
25
Standard of Care
13
13 weeks
Group
Value
95% CI
Dr. Eric Digital Health Intervention
19
Standard of Care
13
Total Number of Participants Who Demonstrated Acceptability (Intervention Arm ONLY)Primary· From day 1 of enrollment until the final day of enrollment (1 year)
Implementation, acceptability: This outcome is to measure acceptability for the intervention group only. Acceptability is the extent to which the innovation is agreeable to a stakeholder. The investigators asked the Agree/Disagree question of "Dr. Eric meets my approval," as self-reported after app completion.
Group
Value
95% CI
Intervention Participants
53
The Number of Participants Who Interacted With All 5 Educational Modules (Intervention Arm ONLY)Primary· From day 1 of enrollment until the final day of enrollment (1 year)
Implementation, adoption: This outcome is for the intervention group only. Th investigators assessed adoption by measuring the number of intervention participants who interacted with all 5 educational modules, based off of data that is recorded by the app.
Group
Value
95% CI
Intervention Arm
59
Number of Participants Who Opt Out of the Texting Messaging Component of the Program (Intervention Arm ONLY)Primary· 3 months
Implementation, fidelity: This outcome is for the intervention group only. Fidelity is the extent to which an intervention is used as intended. This outcome measures the number of participants in the intervention group who opt out of the texting messaging component of the program.
Group
Value
95% CI
Intervention Arm
14
Percentage of Condom Use Among ParticipantsPrimary· 3 months (or 13 weeks)
Efficacy, Consistent Condom Use: This outcome is designed to measure efficacy and is a self-reported outcome and only includes participants who completed follow-up at 13 weeks. Percentages are calculated by dividing the total number of episodes of vaginal intercourse by the total number of times a male condom was used during vaginal intercourse over the past 4 weeks to report percentage of condom use within each arm.
Group
Value
95% CI
Dr. Eric Digital Health Intervention
34.6
Standard of Care
37.3
Percentage of Condom Use Among ParticipantsPrimary· 6 weeks
Efficacy, Consistent Condom Use: This outcome is designed to measure efficacy and is a self-reported outcome. This outcome only includes participants who completed follow-up at 6 weeks and were sexually active in the prior 4 weeks. The percentages are calculated by dividing the total number of episodes of vaginal intercourse by the total number of times a male condom was used during vaginal intercourse over the past 4 weeks to report percentages of condom use within each arm.
Group
Value
95% CI
Dr. Eric Digital Health Intervention
82.5
Standard of Care
47.5
Number of Participants Who Had Intercourse Over the Past 4 WeeksSecondary· 3 month (13 weeks)
Efficacy, Abstinent: This outcome is self-reported where participants are asked if they had penile-vaginal intercourse over the past 4 week. The binary outcome is measured from a "Yes" or "No" response.
Group
Value
95% CI
Intervention Participants Who Completed 3 Month Follow-up Questions
5
Control Participants Who Completed 3 Month Follow-up Questions
9
Number of Participants Who Talked to a Partner About Ways to Prevent Pregnancy Over the Past 3 MonthsSecondary· 3 month (13 weeks)
Efficacy, Talked to a partner about ways to prevent pregnancy over the past 3 months: This outcome is based on self-reported responses on the follow-up survey in which the binary outcome is measured from a "Yes" or "No" response.
Group
Value
95% CI
Intervention Participants Who Completed 3 Month Follow-up Questions
23
Control Participants Who Completed 3 Month Follow-up Questions
29
Number of Participants Who Tested for a Sexually Transmitted Infection Over the Past 3 MonthsSecondary· 3 month (13 weeks)
Efficacy, Tested for a sexually transmitted infection over the past 3 months: This outcome is based on self-reported responses on the follow-up survey, in which the binary outcome is measured from a "Yes" or "No" response.
Group
Value
95% CI
Intervention Participants Who Completed 3 Month Follow-up Questions
13
Control Participants Who Completed 3 Month Follow-up Questions
15
Number of Participants Who Tested for HIV Over the Past 3 MonthsSecondary· 3 month (13 weeks)
Efficacy, Tested for HIV over the past 3 months: This outcome was based on self-reported responses on the follow-up survey in which the binary outcome is measured from a "Yes" or "No" response.
Group
Value
95% CI
Intervention Participants Who Completed 3 Month Follow-up Questions
9
Control Participants Who Completed 3 Month Follow-up Questions
15
Number of Participants Who Consistently Used Condoms at Every IntercourseSecondary· 3 months (or 13 weeks)
Efficacy, Consistent Condom Use at Every Intercourse: This outcome is designed to measure efficacy, is a self-reported outcome and only includes participants who completed follow-up at 13 weeks. Answere are binary (yes/no) to using a condom at every intercourse over the past 3 months.
Group
Value
95% CI
Dr. Eric Digital Health Intervention
12
Standard of Care
13
Sponsor's own description
Early unintended fatherhood and rates of sexually transmitted infections remain national concerns, disproportionately affecting minority, underserved adolescent males, many of whom frequently use emergency departments (EDs) for medical care. EDs must implement effective sexual and reproductive health interventions that are evidence-based and reproducible. This research will conduct pilot testing of a personalized and interactive digital intervention specifically targeting adolescent males entitled Dr. Eric that is theory-based, user-informed, and scalable across EDs.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 9 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969289.